Search Results (146)

Myocardial ischemia/reperfusion (MI/R) injury affects heart attack outcomes. Endothelial cells dysfunction immediately after MI/R, but the key molecules and how to block them remain unclear. We combined single-cell atlas analysis, AI simulation, and experimental single-cell RNA sequencing data from mouse MI/R; we did quality control, cell annotation, hdWGCNA, and differential gene screening to identify endothelial genes. We constructed a protein network with STRING, predicted structure with AlphaFold3, and used AutoDock for molecular docking to find potential drugs. Virtual knockout simulations were used to check gene deletion effects. The compound andrographolide (AG) was tested in in vitro and in vivo MI/R models by measuring cell viability, inflammation, pathway activity, infarct size, and cardiac function. Single-cell analysis showed that S100 calcium binding protein A8 (S100A8) is an important element in vascular inflammation. It promotes inflammation by interacting indirectly with Cluster of differentiation 14 (CD14). Molecular docking showed that AG binds stably to S100A8. In vitro, AG reduced endothelial injury and blocked the IL-17 pathway. In vivo, AG reduced infarct size, improved cardiac function, and lowered S100A8 and IL-17 pathway proteins. Using single-cell analysis, AI, and experiments, we showed that S100A8 is related to MI/R injury. Andrographolide protects microvasculature via the S100A8 pathway, offering a promising treatment approach and new insights into heart injury mechanisms. Full article

Polygonatum cyrtonema Hua (PCH) is traditionally recognized as both an edible and medicinal food source. Its rhizomes contain numerous bioactive compounds, notably polysaccharides and flavonoids, which serve as key constituents in functional food development. However, the cultivation of PCH is often hindered by allelopathic effects, which diminish its quality and restrict its industrial application. To mitigate these allelopathic influences, three types of biochars derived from maize straw (MB), rice husk (RB), and tea stem (TB) were applied at concentrations of 0%, 2%, and 4%. Initially, the physicochemical properties of these biochars were characterized, followed by an evaluation of their impact on (1) the synthesis of quality-related components, secondary metabolites, and allelochemicals within PCH rhizomes and (2) the fundamental physicochemical properties and bacterial community structure of the PCH rhizosphere soil. The findings indicated that the application of 4% RB significantly enhanced the content of total polysaccharides by 48.5%, total flavonoids by 30.2%, total saponins by 28.6%, and total polyphenols by 18.3%, while concurrently reducing protein (PRO) and free amino acid (FAA) concentrations in the rhizomes. Non-targeted metabolomic analyses revealed that biochar amendments (1) upregulated metabolites involved in the citrate cycle and galactose metabolism pathways, thereby facilitating energy supply and precursors for polysaccharide biosynthesis; (2) downregulated metabolites involved in the arginine biosynthesis pathway, which is unfavorable for protein and amino acid synthesis; (3) decreased the abundance of six identified allelochemicals, including 5-hydroxy-L-tryptophan and andrographolide, with the most pronounced effect observed in the 4% TB treatment (T2); (4) improved soil physicochemical parameters such as pH, soil organic matter (SOM), total nitrogen (TN), and available potassium (AK); and (5) altered the rhizosphere bacterial community by enriching beneficial phyla, notably Myxococcota and Gemmatimonadota. These modifications in soil properties and bacterial community composition were closely associated with enhanced rhizome quality and a reduction in allelochemical accumulation. Collectively, the results of this study elucidate the potential mechanisms linking biochar application to allelopathy mitigation, optimization of soil microbial communities, and improvement of PCH rhizome quality. This research provides a theoretical basis for the production of high-quality PCH while concurrently minimizing allelochemical accumulation in its rhizomes. Full article

Light spectrum is a crucial environmental factor influencing plant growth and secondary metabolite production in controlled-environment agriculture. This study investigated the combined effects of light spectral composition on growth performance and andrographolide accumulation in Andrographis paniculata (Burm.f.) cultivated in a plant factory system. Two Thai cultivars, RBR and TTT, were grown under white light and various red–green–blue (R:G:B) LED ratios during the vegetative and flowering stages. Plant morphological traits, biomass accumulation, and andrographolide derivatives (AP1, AP4, AP6, and total AP) were quantified. Growth and biomass production were significantly enhanced under white light and red-enriched spectra, particularly during the vegetative stage, whereas stem elongation exhibited reduced sensitivity to light spectral quality during the flowering stage. In contrast, andrographolide accumulation showed a strong cultivar-dependent response to light spectrum. The TTT cultivar showed pronounced increases in AP1, AP4, AP6, and total AP under blue-enriched spectra, with the 60B:10G:30R treatment producing the highest total diterpenoid content in both cultivars, while the RBR cultivar displayed limited responsiveness to spectral variation. These results demonstrate light spectrum affecting both biomass production and phytochemical accumulation. Optimization of light spectral composition combined with appropriate cultivar selection offers an effective strategy for enhancing pharmaceutical-grade andrographolide production in plant factory systems. Full article

This study presents an Internet of Things (IoT)-assisted semi-open hydroponic system for cultivating Andrographis paniculata under tropical conditions, aiming to enhance biomass productivity, andrographolide (AG) yield, and production efficiency. IoT-assisted hydroponics, non-IoT hydroponics, and soil-based cultivation were compared in 10 m² greenhouses. The IoT system enabled real-time monitoring and adaptive regulation of temperature, relative humidity, light intensity, nutrient solution pH, and electrical conductivity (EC). IoT-assisted hydroponics achieved earlier harvest (≈90 days) and the highest fresh biomass yield (0.409 ± 0.014 kg m⁻²) while maintaining per-plant productivity (15.74 ± 0.54 g plant⁻¹) comparable to soil-based cultivation. Andrographolide concentration reached 25.58 ± 3.36 mg g⁻¹ DW (2.56% w/w), meeting pharmacopeial requirements. Owing to stable environmental regulation and tolerance to high planting density, the IoT system produced the highest areal AG productivity (209.5 mg m⁻²), representing a four- to tenfold increase over the other systems. Despite higher operational costs, IoT-assisted hydroponics achieved the lowest AG unit cost (≈6.77 USD g⁻¹). While most previous studies emphasize tissue-level AG concentration, system-level productivity and cost efficiency under realistic cultivation conditions remain insufficiently explored. Overall, IoT-enabled semi-open hydroponics provides a scalable and economically viable approach for medicinal plant production, bridging the gap between open-field cultivation and fully controlled plant factory systems. Full article

Influenza A viruses constantly threaten the global population, with seasonal outbreaks occurring in different parts of the world, including avian influenza. Severe influenza A virus infections are strongly associated with the cytokine storm, which can contribute significantly to morbidity and even mortality. The virulence and high mutability of these viruses necessitate more effective treatment strategies and regimens to manage patients, especially those with a severe disease. Favipiravir is an antiviral agent approved in Japan for treating influenza virus strains resistant to the current antivirals. The objective of this study is to investigate the combination treatment of Favipiravir paired with selected repurposed drugs to determine the effectiveness of these combinations against influenza A virus replication as well as their effects on cytokine expression. Specific combinations of Favipiravir with Doxycycline, Azithromycin or Ivermectin were identified to be highly synergistic and effective in inhibiting live virus titers of an influenza H3N2 clinical strain by 4 log₁₀. Furthermore, combinations of Favipiravir with Doxycycline or Azithromycin also exhibited immunomodulatory effects on pro-inflammatory cytokines by strongly reducing the relative mRNA expression of IFN-γ, IL-6, TNF-α and IL-1β. Notably, monotherapy with Andrographolide also completely inhibited influenza virus titers by 4 log₁₀. Specific combinations of Favipiravir with Artesunate or Andrographolide revealed additive effects by inhibiting influenza virus titers by about 2 or 1.5 log₁₀, respectively. Our findings indicate that specific drug combinations show promising efficacy and potential in the treatment of influenza and warrant further studies using influenza models of human cell, tissue and animal infection. Full article

Natural compounds have experienced increasing clinical application, but their association with rapid-onset anaphylactoid reactions (ARs) present a significant challenge to their safe use. These ARs, clinically resembling Type I hypersensitivity, are non-IgE-mediated and involve direct mast cell activation, primarily through the human Mas-related G protein-coupled receptor X2 (MRGPRX2). We computationally screened a natural compound library for MRGPRX2 activation. A human MRGPRX2-expressing cell model was established. Cell viability assays (0–80 μM) were performed to determine appropriate drug concentrations. Compared to the controls, Baohuoside I (10 μM), along with Kaempferol-3-O-rutinoside, Epigallocatechin gallate (EGCG), Isochlorogenic Acid B, Baicalin, Andrographolide, Isorhamnetin, and Dehydroandrographolide (all at 20 μM), significantly increased intracellular calcium flux (p < 0.05) and boosted tryptase and β-hexosaminidase secretion (ELISA) (p < 0.05) in mast cells. Furthermore, the degranulation induced by these compounds was inhibited by the MRGPRX2 inhibitor Z3578 at 20 μM. Neutral red staining was employed to observe cellular morphological changes. Specific compounds capable of mediating ARs through MRGPRX2 activation on mast cells were identified. This contributes to safer and more effective drug use by elucidating the potential triggers of ARs. Full article

Background/Objectives: Astrocytes are key regulators of brain energy homeostasis, integrating glucose metabolism with antioxidant support for neuronal function. Dysregulation of these processes contributes to neurodegenerative diseases, including Alzheimer’s disease. Andrographolide, a bioactive diterpenoid from Andrographis paniculata, has been reported to exert neuroprotective effects through the modulation of Wnt/β–catenin signaling and neuronal metabolism; however, its actions on astrocytic metabolic pathways remain insufficiently characterized. Methods: Here, we investigated the effects of andrographolide on metabolic and redox parameters in primary mouse cortical astrocytes. Results: Andrographolide increased glucose uptake and antioxidant capacity without affecting AMPK activation or the activity of core glycolytic enzymes. Instead, it selectively enhanced glucose-6-phosphate dehydrogenase activity, promoting glucose flux through the pentose phosphate pathway in a partially Wnt-dependent manner. This metabolic reprogramming was associated with increased NADPH availability and glutathione levels, together with a reduced ATP/ADP ratio, consistent with a shift toward redox maintenance rather than maximal energy production. Conclusions: Collectively, these findings highlight astrocytic metabolic plasticity as a relevant and underexplored target of andrographolide and support the concept that natural compounds can enhance brain resilience by modulating glial redox metabolism. Full article

Objectives: This study aimed to assess the intestinal permeation behaviors of andrographolide (AG) and 14-deoxy-11,12-didehydroandrographolide (DDAG), diterpene lactones from Andrographis paniculata extract (APE), pure AG, and three distinct source APEs. The effects of different solvents were also investigated. Methods: Solubility investigation was performed using APE. APEs and pure AG were prepared as liqui-masses, cohesive mixtures of APE, solvents, and solid carriers. PXRD, in vitro release, and ex vivo intestinal permeation using the non-everted gut sac method were investigated. Results: Solubility of AG and DDAG in N-methyl-2-pyrrolidone (NMP) > NMP/diethylene glycol monoethyl ether (DG) mixtures > DG. PXRD indicated that crystallinity loss of liqui-mass was affected by solvent’s solvency capacity. The release behaviors of AG and DDAG in phosphate buffer from pure AG and APEs varied depending on their solid state. The release efficiencies of AG and DDAG from liqui-mass systems increased significantly. The apparent permeability (P_app) of AG from pure AG was 0.11 ± 0.05 ×10⁻⁵ cm·s⁻¹, which was 11–25 times less than that of APEs. The P_app of DDAG from various APEs was comparable, ranging between 5.95 and 7.37 × 10⁻⁵ cm·s⁻¹. The presence of a solvent, specifically NMP, in liqui-mass significantly enhanced the release rate and permeation flux. The P_app of AG and DDAG from liqui-mass increased by factors of 1.0–2.3 and 1.1–2.7, respectively. Conclusions: This study is the first to emphasize the differences in the release and intestinal permeation characteristics of AG and DDAG from APEs. These findings offer essential insights into the intestinal permeation behavior of diterpene lactones, along with a straightforward mechanistic strategy for enhancement. Full article

Background: Prostate cancer remains a major contributor to cancer-related morbidity and mortality worldwide, emphasizing the need for safer and more effective therapeutic options. Andrographolide, a diterpenoid lactone derived from Andrographis paniculata, has shown promising anticancer activity, yet its effects on microRNA (miRNA) regulation in prostate cancer remain insufficiently explored. Methods: In this study, we evaluated the cytotoxic and molecular effects of andrographolide on two human prostate cancer cell lines, PC3 and LNCaP, along with HEK-293 cells as a noncancerous model. Results: Cell viability assessment using the MTT assay revealed dose-dependent cytotoxicity, with 24 h IC₅₀ values of 82.31 µM for PC3, 68.79 µM for LNCaP, and 133.9 µM for HEK-293 cells. Subsequent expression analysis of key oncogenic and tumor suppressor miRNAs demonstrated that andrographolide induced the upregulation of miR-16-5p, miR-34a-5p, and miR-200a-5p miRNAs implicated in apoptosis, proliferation control, and androgen receptor signaling. In contrast, the expression of oncomiRs miR-21-5p and miR-221-5p showed minimal or nonsignificant changes, reflecting the complex and context-specific roles of miRNAs in prostate cancer. Gene expression profiling further indicated differential transcriptional responses between the two prostate cancer cell lines, consistent with their distinct molecular backgrounds. Conclusions: Although HEK-293 cytotoxicity and previously reported nephrotoxic effects warrant caution, these results support the potential of andrographolide as an adjuvant phytochemical capable of modulating clinically relevant miRNAs in prostate cancer. Future studies investigating optimized delivery systems and validating direct miRNA targets may help advance andrographolide toward safer and more targeted therapeutic applications. Full article

Background/Objectives: Andrographolide (Andro), a natural diterpenoid lactone, possesses a wide range of pharmacological properties, including notable anti-inflammatory, antioxidant, antitumor, and immunomodulatory activities. Despite its acknowledged therapeutic promise, the exact protective mechanisms underlying its efficacy against acute liver injury (ALI) are still not fully understood. Consequently, determining the molecular mechanisms through which andrographolide alleviates ALI is of substantial scientific and clinical relevance. Methods: Andrographolide’s potential targets and pharmacological mechanisms against liver injury were initially identified using network pharmacology and molecular docking. An acute liver injury (ALI) rat model was induced by intraperitoneal injection of lipopolysaccharide (LPS). The therapeutic efficacy of andrographolide in ALI was evaluated by examining liver histopathology, measuring liver function and oxidative stress markers, and quantifying pro-inflammatory cytokine levels. Meanwhile, the expression of key constituents along the NLRP3/caspase-1/GSDMD signaling axis was quantified using RT-qPCR and Western blotting. In parallel, the protective effect of andrographolide via the canonical NLRP3/caspase-1/GSDMD pyroptosis pathway was further examined in vitro using LPS-plus-ATP-stimulated rat hepatocyte BRL-3A cells. Results: Network pharmacology analysis predicted that andrographolide (Andro) protects against liver injury mainly by targeting core regulators of pyroptosis. Molecular docking simulations further indicated stable binding interactions between Andro and key proteins involved in the pyroptotic pathway, such as NLRP3, ASC, GSDMD, and CASP1. These predictions were experimentally confirmed. Andro administration notably mitigated histopathological alterations, restored serum liver function indicators, lowered pro-inflammatory cytokine levels, and alleviated oxidative stress. Importantly, Andro substantially suppressed the expression of critical mediators along the pyroptosis signaling cascade. Conclusions: This study demonstrates that andrographolide (Andro) ameliorates acute liver injury (ALI) by specifically inhibiting the NLRP3/Caspase-1/GSDMD-mediated pyroptosis pathway. By elucidating this underlying molecular mechanism, our work highlights Andro’s potential as a novel and promising therapeutic candidate for ALI. Full article

A high-performance liquid chromatography method coupled with diode array detection (HPLC-DAD) was developed for simultaneous quantification of andrographolide (AG) and 14-deoxy-11,12-didehydroandrographolide (DDAG) in rat plasma. A salt-assisted liquid–liquid extraction (SALLE) procedure was optimized, with MgSO₄ yielding the highest extraction efficiency (>90% for both AG and DDAG), outperforming conventional solvent extraction, and being comparable to solid-phase extraction. The method exhibited acceptable linearity (125–2000 ng/mL, R² > 0.99), with low limits of detection and quantification of 60 and 70 ng/mL for AG and 201 and 234 ng/mL for DDAG, respectively, while adhering to the ICH M10 criteria for accuracy, precision, and stability under various storage conditions. Stability testing of the prepared samples demonstrated that >99% AG and 95% DDAG were retained when stored at low temperatures, specifically below 4 °C. The developed method was successfully applied in a pharmacokinetic study following oral administration of Andrographis paniculata extract (containing AG 7.5 mg/kg) to healthy Wistar rats. The SALLE-HPLC-DAD method developed herein enables selective AG quantification without significant matrix interference. In conclusion, this study introduces an alternative sample preparation and analytical method that is fast, cost-effective, and reliable, making it suitable for pharmacokinetic studies of the principal biomarker of Andrographis paniculata. Full article

Andrographis paniculata, a medicinal plant widely found in Asia, contains andrographolide as its main active compound, known for its wide-ranging pharmacological effects, including anti-inflammatory, anti-cancer, anti-obesity, and anti-diabetic properties. Recent investigations have highlighted the anti-infective potential of andrographolide and its derivatives, with demonstrated antiviral, antibacterial, and antimalarial activities. This review summarizes progress in andrographolide’s anti-infective applications, focusing on its structure–activity relationship (SAR) and mechanisms of action. Researchers have used semi-synthetic methods, such as esterification, oxidation, Michael addition, salification, and hybrid design, to enhance andrographolide’s physicochemical properties and biological activity. These derivatives show potent antiviral activity against RNA and DNA viruses, antibacterial activity against Gram-positive and Gram-negative bacteria, antifungal effects, and antiparasitic activity against Plasmodium spp. and Leishmania spp. Nevertheless, poor solubility and limited bioavailability still hinder their clinical translation. Strategies such as nano delivery systems and β-cyclodextrin complexes are discussed to improve bioavailability. Although andrographolide itself has not received regulatory approval as a stand-alone drug, several andrographolide-containing preparations have been clinically used in certain countries. Overall, this review brings together evidence on antiviral, antibacterial, antifungal, and antiparasitic activities, linking them with structure–activity trends and pharmacokinetic insights, thereby providing a consolidated foundation for future development and clinical translation. Full article

Background: Glioblastoma multiforme (GBM) is an aggressive primary brain malignancy associated with poor prognosis and limited therapeutic options. Nanoparticle-based drug delivery systems provide a promising strategy to enhance treatment efficacy by circumventing barriers such as the blood–brain barrier. This study was conducted to synthesize, characterize, and evaluate the in vitro anticancer potential of andrographolide–iron oxide nanoparticles (AG-IONPs) against GBM cells. Methods: Iron oxide nanoparticles (IONPs) were synthesized through co-precipitation and subsequently functionalized with andrographolide. Morphology, size, and surface charge were assessed by transmission electron microscopy (TEM), dynamic light scattering (DLS), and zeta potential analysis. Functionalization was confirmed by Fourier-transform infrared spectroscopy (FTIR) and UV–Vis spectroscopy. Nanoparticle stability was monitored over three months. Cytotoxicity toward DBTRG-05MG cells was evaluated using MTT assays at 24, 48, and 72 h, while anti-migratory effects were determined using scratch-wound assays. Results: TEM analysis revealed nearly spherical IONPs (7.0 ± 0.15 nm) and AG-IONPs (13.5 ± 1.25 nm). DLS indicated an increased hydrodynamic diameter following functionalization, while zeta potential values decreased from +21.22 ± 1.58 mV to +8.68 ± 0.87 mV. The successful incorporation of andrographolide was confirmed by FTIR and UV–Vis spectra. AG-IONPs demonstrated excellent colloidal stability for up to three months. Cytotoxicity assays revealed a dose- and time-dependent decrease in cell viability, with LC₅₀ values declining from 44.01 ± 3.23 μM (24 h) to 15.82 ± 2.30 μM (72 h). Scratch-wound assays further showed significant inhibition of cell migration relative to untreated controls. Conclusions: AG-IONPs exhibit favorable physicochemical properties, long-term stability, and potent anti-proliferative and anti-migratory effects against GBM cells in vitro. These findings support their potential as a multifunctional therapeutic platform, warranting further preclinical investigation. Full article

Andrographolide (ADG) is a typical poorly water-soluble drug, and a co-amorphous strategy was used here to improve its aqueous solubility. Co-amorphous systems of ADG and amino acids with a 1:1 molar ratio were screened via the neat ball milling method. L-lysine (Lys) and L-tryptophan (Trp) can be used as co-formers with ADG, forming a co-amorphous phase, which was confirmed by powder X-ray diffraction, IR and Raman spectroscopy. ADG-Trp showed poor solubility at 37 °C, which was close to that of raw ADG (0.08 mg·mL⁻¹). ADG-Lys showed unexpectedly enhanced solubility, at 0.5 mg·mL⁻¹ in the media of water and PBS (pH 7.4) and 0.3 mg·mL⁻¹ in the medium of HCl buffer (pH 1.2) at 37 °C. ADG-Lys showed good storage stability for 5 months, but its thermal stability was poor and it could recrystallize at 100 °C. Compared with ADG-Trp, ADG-Lys has weaker hydrogen bonding interactions and stronger hydrophobic interactions related to ADG molecules, which might cause the unusual enhancement in solubility. To our knowledge, ADG-Lys prepared in this work shows the maximum ADG content (70 wt.%) and the highest ADG solubility among the reported ADG amorphous solid dispersions and co-amorphous systems. Full article

The increasing demand for sustainable disease management in aquaculture has intensified interest in plant-based therapeutics. This study evaluated the formulation and efficacy of andrographolide-loaded nanostructured lipid carriers (AND-NLCs) in Nile tilapia (Oreochromis niloticus) challenged with Streptococcus agalactiae ENC06. AND-NLCs were prepared by the phase-inversion technique and characterized by dynamic light scattering, transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), and in vitro release profiling. Antibacterial activity was assessed by measuring inhibition zone diameters, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Growth performance, feed utilization, hepatosomatic index (HSI), and disease resistance were evaluated over a 60-day feeding trial. The AND-NLCs exhibited an optimal particle size (189.6 nm), high encapsulation efficiency (90.58%), sustained release, and structural stability. Compared to the free AND and control group, AND-NLC supplementation significantly improved growth, feed efficiency, HSI, and positive allometric growth. It also enhanced survival (73.3%) and relative percent survival (RPS = 65.6%) following S. agalactiae ENC06 infection. Antibacterial efficacy and physiological responses showed positive correlations with nanoparticle characteristics. These findings suggest that AND-NLCs enhance bioavailability and therapeutic efficacy, supporting their potential as a functional dietary additive to promote growth and improve disease resistance in tilapia aquaculture. Full article